ARTICLE | Company News
Pharmos sells ophthalmics to BOL
October 10, 2001 7:00 AM UTC
PARS sold its loteprednol etabonate (LE) ophthalmic business to Bausch & Lomb (BOL). BOL paid $25 million in cash for PARS's Lotemax and Alrex, which BOL already markets under a 1995 deal, and BOL is ...